Navigation Links
CBDM.T, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market
Date:4/28/2010

According to CBDM.T®, the market and business intelligence company, the Dry Eye market is huge and growing valued at 1.7 billion USD in 2009 with an annual growth of about 10 to 11%. The Dry Eye market could account for more than 2.4 billion USD by 2014.

Paris, France (PRWEB) April 28, 2010 -- Dry eye disease (DED) is one of the most frequently encountered ocular morbidities. 25 % percent of patients who visit ophthalmic clinics report symptoms of dry eye, making it a growing public health problem and one of the most common conditions seen by eye care practitioners. Dry eye affects an estimated 20 to 30 million people in the United States and is one of the most common reasons that people visit their eye doctor. Dry eye’s prevalence estimation is very variable but we could estimate that more than 70 million people are or will be affected by dry ocular symptoms. According to CBDM.T, Dry Eye represents one of the fastest growing pharmaceutical product categories in the ophthalmology market at over 10% growth per annum to 2014. The market potential for dry eye drugs is projected to reach 1 billion USD by 2015.

The first line of treatment is usually eye drops that act as artificial tears and give some temporary relief. Restasis (cyclosporine A ophthalmic emulsion) 0.05% is the first approved prescription product in the United States for the treatment of dry eye disease. Restasis (Allergan) sales were 270 million USD in 2006s to 444 million USD by 2008.

In 2008, more than 15 products were under development from discovery, preclinical, clinical phase 1, clinical phase 2 (5 products) to clinical phase 3 with 8 products. The leading companies in this market are Novartis, Alcon (acquired by Novartis), Bausch & Lomb, Vistakon (J&J), Allergan, Pfizer and AMO (Abbott Medical Optics Inc).

According to CBDM.T®, the market and business intelligence company, the Dry Ey
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. InBoundMarketingPR: Cord Blood America Newest Inbound Marketing Client
2. Top DTC Marketers Choose Obama Over Romney and Palin
3. Industry Veteran Bob O'Hara to Share Insights on Enterprise WLAN Market at Interop Las Vegas 2010
4. Peoria and Baltimore Serve as Test Markets for New Spot On Energy Product
5. Human Touch Returns to High Point Market with the First iPhone/iPod Touch Controlled Massage Chair
6. Global Dental Laboratories Market to Exceed $14.5 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
7. 10,000 New, Reusable Advertising and Promotional Items Extend Marketing Muscle, Free 24-Hour Rush Service
8. Interact Marketing to Provide Online Services for England, Inc.
9. Chiropractic Traffic CEO Matt Prados Releases the Easiest and Fastest Free Chiropractic Marketing Method Known to Man
10. Donors Welcome the Advance Market Commitment's First Long-Term Supply Commitments
11. Ziosoft Expands PhyzAiodynamic Diagnostic Solutions into Greek Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBDM.T, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market 
(Date:3/31/2015)... (PRWEB) March 31, 2015 A report ... (CASA) at Columbia University states that four out of ... U.S. and enter state juvenile justice systems either test ... under the influence of drugs or alcohol when committing ... Despite this high incidence of substance-related juvenile crime, only ...
(Date:3/31/2015)... A' Design Award and Competition is pleased ... Daniel Dion has been announced as a winner of ... Devices and Research Equipment Design Competition Category. ... behind the award winning Medical Product design Bruker EVOQ ... direction of Dr. Rohan Thakur and the Bruker team ...
(Date:3/31/2015)... PharmMD CEO Robert Yeager ... newly created, senior executive role of Chief Technology Officer ... delivery of high quality, efficient, reliable, and secure applications, ... momentum as a market innovator for Part D Star ... “We were very strategic in our search for the ...
(Date:3/31/2015)... TN (PRWEB) March 31, 2015 Dr. ... welcomes warmer temperatures and sunshine; however, it's important to be ... eye damage. Experts say more than 90 percent ... few precautions and wearing safety glasses. Dr. Shofner shares five ... this season. , 1) Yard Work. While using a lawn ...
(Date:3/31/2015)... Texas (PRWEB) March 31, 2015 ... oxygen therapy equipment and supplies, was recently selected to ... identify online merchants that offer a great shipping experience, ... sites that demonstrate a track record of on-time shipping ... Inc. website, shoppers will see a Google Trusted Store ...
Breaking Medicine News(10 mins):Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 2Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 3Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 4Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:PharmMD Places Victor Mattingly in C-Suite, Company Focused on Medication Therapy Management and Part D Star Ratings 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 3Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 4Health News:Sleep Restfully, Inc. now recognized as Google Trusted Store 2
... Addictions ... ... – The YWCA’s Week Without Violence kicks off today, acting as a sober reminder that ... workers throughout the world. Those interested becoming community support workers can enroll in the Addictions ...
... Former pros have lower risk of heart disease, suggesting early ... News) -- A recent report linking professional football to an ... rooms across the nation, but the news for aging athletes ... disease risk factors than other men in the same age ...
... ... Speech Understanding and Discrete Reportable Transcription at the MGMA 2009 Annual Conference, October 11th ... ... ), will be demonstrating the benefits of M*Modal Speech Understanding and Discrete Reportable Transcription ...
... Inc. (Nasdaq: IFLG ), a leading technology provider ... industries, today announced that it has retained SSG Capital ... West Conshohocken, PA to assist InfoLogix in exploring its ... transactions at virtually every level of the capital structure ...
... ... banks are not lending, International Tenant Representative Alliance revisits the most efficient option for ... ... Ronald Pollina, Ph.D., Principal of Pollina Corporate Real Estate and Chairman of the International ...
... The following is the text of a letter to Senator ... Honorable Harry Reid , Majority Leader , United States Senate , ... health care reform debate very carefully. We applaud you and the ... most important and most difficult public policy issue. And, we applaud ...
Cached Medicine News:Health News:YWCA's Week Without Violence Oct. 11-17 a Reminder That Community Support Workers Remain in High Demand 2Health News:Ex-NFL Players Hold Their Own Health-Wise 2Health News:Discrete Reportable Transcription to Populate the EHR/EMR With Physician Dictated Reports 2Health News:Discrete Reportable Transcription to Populate the EHR/EMR With Physician Dictated Reports 3Health News:InfoLogix Announces News Related to its Recent Corporate Development Initiatives 2Health News:Right Now Sale/Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 2Health News:Right Now Sale/Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 3Health News:Right Now Sale/Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 4Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 2Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 3Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 4Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 5Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 6Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 7Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 8Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 9Health News:Concord Coalition Leaders Send Letter to Senator Reid on Healthcare Reform Bill 10
(Date:3/31/2015)... -- Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: ... its planned bullous pemphigoid (BP) clinical development for bertilimumab, ... is an orphan auto-immune blistering disease of the skin ... Europe . As previously announced, ... II clinical trial in Israel ...
(Date:3/31/2015)... , March 31, 2015 ANI Pharmaceuticals, ... launch of Propafenone Hydrochloride 150mg, 225mg and 300mg oral ... arrhythmias. The overall US market for Propafenone Hydrochloride 150mg, ... per IMS Health. Arthur S. Przybyl ... pleased to announce the launch of our fourth product ...
(Date:3/31/2015)...   Unique Pharmaceuticals , a 503B outsourcing facility, ... company has initiated sterile compounding operations meeting the newly ... company is to meet and exceed industry standards," said ... new regulations is validation of our quality management system ... our industry, investing in its continued success and are ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
... Sept. 29 NuVasive, Inc. (Nasdaq: NUVA ), a ... surgical treatments for the spine, announced today that Kevin O,Boyle, ... present at the JMP Securities Healthcare Focus Conference at The ... Tuesday, October 6, 2009, at 12:00 noon ET. , ...
... , , SAN FRANCISCO, Sept. 24 ... groundbreaking PROSPECT ( P roviding R egional O bservations to ... C oronary T ree) clinical trial. PROSPECT is the ... in unexpected heart attacks and the natural progression of coronary artery disease. ...
Cached Medicine Technology:NuVasive to Present at the JMP Securities Healthcare Focus Conference 2NuVasive to Present at the JMP Securities Healthcare Focus Conference 3Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 2Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 3Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease 4
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
Cholesterol/HDL Standard 50 mg/dl....
For the quantitative determination of High Density Lipoprotein in serum. Available in liquid type. Polyethylene glycol (6000) precipitating reagent. Linearity: 200 mg/dl....
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: